Mary Qiu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mary Qiu has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Jessie Wang
Department of Ophthalmology and Visual Science, University of Chicago Medical Center, Chicago, IL, USA
6 shared publications Dimitra Skondra
Department of Ophthalmology and Visual Science, University of Chicago, Chicago, IL, USA
4 shared publicationsJessie Wang
Department of Ophthalmology & Visual Sciences, University of Chicago, Chicago, IL, USA
4 shared publicationsDavid Dao
Elman Retina Group, Rosedale, MD, USA
3 shared publicationsIan Patterson
Department of Ophthalmology, The University of Chicago, Chicago, Illinois, USA
3 shared publications- Jacob A. Kanter
Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
3 shared publications
Latest Publications
- Open Access
- 1 November 2026
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 20, 1-8
Trends in the Initial Management of Primary Angle-Closure Glaucoma: A 2010-2025 Study of Peripheral Iridotomy versus Phacoemulsification
- 1 November 2026
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 20, 1-8
Open AccessTrends in the Initial Management of Primary Angle-Closure Glaucoma: A 2010-2025 Study of Peripheral Iridotomy versus Phacoemulsification
- 4 August 2026
- Published by Elsevier in Ophthalmology Glaucoma
Standardizing Glaucoma Fellowship Evaluation
- 4 August 2026
- Published by Elsevier in Ophthalmology Glaucoma
Standardizing Glaucoma Fellowship Evaluation
- 21 May 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 291, 277-281
The Neovascular Ocular Hypertension Spectrum: A Novel Classification of Neovascular Glaucoma
- 21 May 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 291, 277-281
The Neovascular Ocular Hypertension Spectrum: A Novel Classification of Neovascular Glaucoma
- Open Access
- 26 January 2026
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 41, 102522
Baerveldt-350 with adjunctive goniotomy: One-year outcomes
- 26 January 2026
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 41, 102522
Open AccessBaerveldt-350 with adjunctive goniotomy: One-year outcomes
- Open Access
- 1 December 2025
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 19, 4373-4379
SCOPING: A Multidisciplinary Treatment Protocol for Neovascular Glaucoma with Completely Open or Partially Open Angles
Introduction: A standardized multidisciplinary treatment protocol for NVG was developed in 2020 at the University of Chicago and has been termed Salvaging the Conventional Outflow Pathway in Neovascular Glaucoma (SCOPING). We describe 9 eyes with anterior segment neovascularization and at least partially open angles that underwent the SCOPING protocol to suppress the underlying neovascular drive, control intraocular pressure, and medically or surgically salvage the angle whenever possible. Methods: Nine eyes from 8 patients with first-time anterior segment neovascularization, at least partially open angles, and normal or elevated IOP were treated with 6 serial monthly intravitreal bevacizumab injections interspersed with pan-retinal photocoagulation. Results: Five eyes with completely open angles without any peripheral anterior synechiae and each achieved and/or maintained physiologic IOP without requiring surgery. The other 4 eyes presented with partially open angles. Three out of these 4 eyes required subsequent IOP-lowering surgery. None of the 9 eyes developed recurrence of anterior segment neovascularization during the treatment protocol. Discussion: This protocol may be utilized to salvage the conventional outflow pathway for patients with partially or completely open angles. The etiology and diagnosis of neovascular glaucoma have been established. Current treatment strategies include reduction of neovascular drive including panretinal photocoagulation, intravitreal injections, intraocular pressure lowering medications, and filtration surgery. However, a protocol has not been developed to treat neovascular glaucoma (NVG). Our SCOPING protocol may be helpful for glaucoma specialists in treating patients with neovascular glaucoma.
- 1 December 2025
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 19, 4373-4379
Open AccessSCOPING: A Multidisciplinary Treatment Protocol for Neovascular Glaucoma with Completely Open or Partially Open Angles
Introduction: A standardized multidisciplinary treatment protocol for NVG was developed in 2020 at the University of Chicago and has been termed Salvaging the Conventional Outflow Pathway in Neovascular Glaucoma (SCOPING). We describe 9 eyes with anterior segment neovascularization and at least partially open angles that underwent the SCOPING protocol to suppress the underlying neovascular drive, control intraocular pressure, and medically or surgically salvage the angle whenever possible. Methods: Nine eyes from 8 patients with first-time anterior segment neovascularization, at least partially open angles, and normal or elevated IOP were treated with 6 serial monthly intravitreal bevacizumab injections interspersed with pan-retinal photocoagulation. Results: Five eyes with completely open angles without any peripheral anterior synechiae and each achieved and/or maintained physiologic IOP without requiring surgery. The other 4 eyes presented with partially open angles. Three out of these 4 eyes required subsequent IOP-lowering surgery. None of the 9 eyes developed recurrence of anterior segment neovascularization during the treatment protocol. Discussion: This protocol may be utilized to salvage the conventional outflow pathway for patients with partially or completely open angles. The etiology and diagnosis of neovascular glaucoma have been established. Current treatment strategies include reduction of neovascular drive including panretinal photocoagulation, intravitreal injections, intraocular pressure lowering medications, and filtration surgery. However, a protocol has not been developed to treat neovascular glaucoma (NVG). Our SCOPING protocol may be helpful for glaucoma specialists in treating patients with neovascular glaucoma.
- Open Access
- 23 August 2025
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 40, 102412
Suture stent insertion into an over draining tube shunt lumen via single paracentesis
- 23 August 2025
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 40, 102412
Open AccessSuture stent insertion into an over draining tube shunt lumen via single paracentesis
- Open Access
- 1 August 2025
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 19, 2859-2870
Cyclodialysis Surgery for Glaucoma Management: A Systematic Review and Meta-Analysis of 100 Years of Clinical Evidence
Synopsis: A meta-analysis of over 4000 glaucoma cases over 100 years of surgical experience demonstrates that cyclodialysis surgery is effective in lowering intraocular pressure (IOP) as an uveoscleral outflow enhancing procedure. Objective: To conduct a systematic review and meta-analysis evaluating the clinical efficacy and safety of surgical cyclodialysis in lowering intraocular pressure in glaucoma patients. Methods: A comprehensive search of PubMed, Cochrane, Web of Science, and EMBASE identified peer-reviewed interventional studies involving surgical cyclodialysis for IOP reduction. Key outcome measures included long-term IOP control, medication burden, and adverse event incidence. The meta-analysis was registered with PROSPERO (ID: CRD42025632759). Results: Forty studies spanning more than a century and including 4082 eyes were analyzed. Most studies were observational and non-randomized, with 75% employing ab-externo and 25% ab-key techniques. Given the evolution of surgical techniques and populations over time, analyses accounted for heterogeneity in outcome reporting. Across all studies, the average qualified success rate was 72.3% (range: 33– 97%) over follow-up periods of 6 to 132 months. Ab-interno approaches showed slightly higher efficacy and fewer complications. Durability varied, with reduced outcomes in refractory and advanced glaucoma. Complications such as hyphema, hypotony, and vision loss were infrequent. Notably, newer ab-interno techniques demonstrated improved outcomes in IOP reduction, safety, and procedural longevity. Conclusion: Cyclodialysis remains a viable and effective surgical option for enhancing uveoscleral outflow in glaucoma management. While outcomes vary by patient severity and surgical technique, particularly with older methods, modern ab-interno approaches offer enhanced efficacy and safety—especially in mild to moderate cases.
- 1 August 2025
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 19, 2859-2870
Open AccessCyclodialysis Surgery for Glaucoma Management: A Systematic Review and Meta-Analysis of 100 Years of Clinical Evidence
Synopsis: A meta-analysis of over 4000 glaucoma cases over 100 years of surgical experience demonstrates that cyclodialysis surgery is effective in lowering intraocular pressure (IOP) as an uveoscleral outflow enhancing procedure. Objective: To conduct a systematic review and meta-analysis evaluating the clinical efficacy and safety of surgical cyclodialysis in lowering intraocular pressure in glaucoma patients. Methods: A comprehensive search of PubMed, Cochrane, Web of Science, and EMBASE identified peer-reviewed interventional studies involving surgical cyclodialysis for IOP reduction. Key outcome measures included long-term IOP control, medication burden, and adverse event incidence. The meta-analysis was registered with PROSPERO (ID: CRD42025632759). Results: Forty studies spanning more than a century and including 4082 eyes were analyzed. Most studies were observational and non-randomized, with 75% employing ab-externo and 25% ab-key techniques. Given the evolution of surgical techniques and populations over time, analyses accounted for heterogeneity in outcome reporting. Across all studies, the average qualified success rate was 72.3% (range: 33– 97%) over follow-up periods of 6 to 132 months. Ab-interno approaches showed slightly higher efficacy and fewer complications. Durability varied, with reduced outcomes in refractory and advanced glaucoma. Complications such as hyphema, hypotony, and vision loss were infrequent. Notably, newer ab-interno techniques demonstrated improved outcomes in IOP reduction, safety, and procedural longevity. Conclusion: Cyclodialysis remains a viable and effective surgical option for enhancing uveoscleral outflow in glaucoma management. While outcomes vary by patient severity and surgical technique, particularly with older methods, modern ab-interno approaches offer enhanced efficacy and safety—especially in mild to moderate cases.
- Open Access
- 4 July 2025
- Published by Elsevier in Advances in Ophthalmology Practice and Research
- Vol. 5  (4) , 227-234
Young glaucoma specialist practice patterns: Why do you do what you do?
- 4 July 2025
- Published by Elsevier in Advances in Ophthalmology Practice and Research
- Vol. 5  (4) , 227-234
Open AccessYoung glaucoma specialist practice patterns: Why do you do what you do?
- 10 June 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18  (6) , e266258
Presumed bupropion-associated acute bilateral angle-closure with uveal effusions
Herein, we report a case of a woman in late adulthood with bilateral acute angle closure crisis (AACC) secondary to uveal effusions exacerbated by bupropion. Near vision was 20/20 in both eyes and intraocular pressure (IOP) was 40 and 45 mmHg in the right (OD) and left eye (OS), respectively. We noted bilateral chemosis, uniformly shallow anterior chambers and clear crystalline lenses. Gonioscopy demonstrated 360° of appositional closure. Autorefraction demonstrated a 3-diopter myopic shift. B-scan, anterior segment ocular coherence tomography and ultrasound biomicroscopy revealed shallow uveal effusions with anterior rotation of the ciliary body. We diagnosed bilateral secondary AACC due to bilateral uveal effusions. After a medication review, we suspected bupropion as a contributing factor and recommended discontinuation. We started atropine, prednisolone and IOP-lowering medications with subsequent normalisation of IOP and resolution of choroidal effusions. A thorough review of medications and medical history is critical when evaluating patients with bilateral AACC.
- 10 June 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18  (6) , e266258
Presumed bupropion-associated acute bilateral angle-closure with uveal effusions
Herein, we report a case of a woman in late adulthood with bilateral acute angle closure crisis (AACC) secondary to uveal effusions exacerbated by bupropion. Near vision was 20/20 in both eyes and intraocular pressure (IOP) was 40 and 45 mmHg in the right (OD) and left eye (OS), respectively. We noted bilateral chemosis, uniformly shallow anterior chambers and clear crystalline lenses. Gonioscopy demonstrated 360° of appositional closure. Autorefraction demonstrated a 3-diopter myopic shift. B-scan, anterior segment ocular coherence tomography and ultrasound biomicroscopy revealed shallow uveal effusions with anterior rotation of the ciliary body. We diagnosed bilateral secondary AACC due to bilateral uveal effusions. After a medication review, we suspected bupropion as a contributing factor and recommended discontinuation. We started atropine, prednisolone and IOP-lowering medications with subsequent normalisation of IOP and resolution of choroidal effusions. A thorough review of medications and medical history is critical when evaluating patients with bilateral AACC.
- Open Access
- 9 April 2025
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 38, 102328
Post-operative cosmesis of autologous capsular patch grafts in tube shunt surgery: Case series of 18 eyes
- 9 April 2025
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 38, 102328
Open AccessPost-operative cosmesis of autologous capsular patch grafts in tube shunt surgery: Case series of 18 eyes